MD4282B1 - Use of polyoxometalate complexes with central selenium atoms as compounds possessing antitumor activity - Google Patents
Use of polyoxometalate complexes with central selenium atoms as compounds possessing antitumor activity Download PDFInfo
- Publication number
- MD4282B1 MD4282B1 MDA20130003A MD20130003A MD4282B1 MD 4282 B1 MD4282 B1 MD 4282B1 MD A20130003 A MDA20130003 A MD A20130003A MD 20130003 A MD20130003 A MD 20130003A MD 4282 B1 MD4282 B1 MD 4282B1
- Authority
- MD
- Moldova
- Prior art keywords
- antitumor activity
- central
- compounds possessing
- selenium atoms
- possessing antitumor
- Prior art date
Links
- 230000000259 anti-tumor effect Effects 0.000 title abstract 3
- 150000001875 compounds Chemical class 0.000 title abstract 3
- 239000013460 polyoxometalate Substances 0.000 title abstract 3
- 125000003748 selenium group Chemical group *[Se]* 0.000 title abstract 2
- 239000003814 drug Substances 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention relates to medicine, namely to the use of polyoxometalate complexes as compounds possessing antitumor activity.According to the invention, the use of polyoxometalate complexes with central selenium atoms of formula Na7¢Cu3Na3(H2O)9(SeW9O33)2]·nH2O, where n = 11,5; 13; 23, is claimed, as compounds possessing antitumor activity.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MDA20130003A MD4282C1 (en) | 2012-12-11 | 2012-12-11 | Use of polyoxometalate complexes with central selenium atoms as compounds possessing antitumor activity |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MDA20130003A MD4282C1 (en) | 2012-12-11 | 2012-12-11 | Use of polyoxometalate complexes with central selenium atoms as compounds possessing antitumor activity |
Publications (2)
Publication Number | Publication Date |
---|---|
MD4282B1 true MD4282B1 (en) | 2014-04-30 |
MD4282C1 MD4282C1 (en) | 2014-11-30 |
Family
ID=50685409
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MDA20130003A MD4282C1 (en) | 2012-12-11 | 2012-12-11 | Use of polyoxometalate complexes with central selenium atoms as compounds possessing antitumor activity |
Country Status (1)
Country | Link |
---|---|
MD (1) | MD4282C1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105859820B (en) * | 2016-03-31 | 2017-09-05 | 中北大学 | Folic acid-wrapped dehydrocholic acid-polymolybdenum oxide cluster-pyrene hybrid and preparation method thereof |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS62230619A (en) * | 1986-03-31 | 1987-10-09 | Poritoronikusu:Kk | Alkali salt of heteropolyacid ion |
JPH01249725A (en) * | 1988-03-30 | 1989-10-05 | Terumo Corp | Antitumor agent |
JPH0283328A (en) * | 1988-09-20 | 1990-03-23 | Terumo Corp | Antitumor agent |
JPH02204415A (en) * | 1989-02-03 | 1990-08-14 | Terumo Corp | Antitumor agent |
JPH02204416A (en) * | 1989-02-03 | 1990-08-14 | Terumo Corp | Antitumor agent |
DE19825746A1 (en) * | 1998-06-09 | 1999-12-16 | Biosyn Arzneimittel Gmbh | Combination of selenium-containing compounds with cytostatics |
CN1150905C (en) * | 1998-12-29 | 2004-05-26 | 东北师范大学 | Application of Ninetungsten Trititania Silicate in Preparation of Drugs for Treating Tumors |
CN1256331C (en) * | 2003-09-09 | 2006-05-17 | 东北师范大学 | Heteropoly acid 5-fluorouracil salt antitumor drug and its synthesis method |
CN100548311C (en) * | 2007-06-13 | 2009-10-14 | 中国科学技术大学 | Application and the fast preparation method of sodium thiosulfate in preparation clinical selenium-complementing and treatment cancer drug |
MD4014C2 (en) * | 2009-04-23 | 2010-09-30 | Татьяна ГУЦУЛ | Polyoxometalate complexes with antitumor activity |
-
2012
- 2012-12-11 MD MDA20130003A patent/MD4282C1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
MD4282C1 (en) | 2014-11-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2015010125A (en) | Pyridazinone-amides derivatives. | |
PH12016500225B1 (en) | Novel quinoline-substituted compound | |
AU2014270524A8 (en) | 2-phenylimidazo [1,2-a]pyrimidines as imaging agents | |
PH12014500248B1 (en) | Treatment of breast cancer | |
MX2015009209A (en) | Substituted pyrrolopyrimidine compounds, compositions thereof, and methods of treatment therewith. | |
PH12014502496B1 (en) | Bicyclically substituted uracils and the use thereof | |
NZ705313A (en) | Novel 4,6-disubstituted aminopyrimidine derivatives | |
PH12014502032A1 (en) | Treatment of brain cancer | |
GEP201706690B (en) | Novel process for making compounds for use in treatment of cancer | |
MX2013000009A (en) | Process for the preparation of the l-arginine salt of perindopril. | |
IN2015DN00950A (en) | ||
MX2015014470A (en) | Combretastatin analogs. | |
MD4282B1 (en) | Use of polyoxometalate complexes with central selenium atoms as compounds possessing antitumor activity | |
MX2016006807A (en) | Imidazole derivatives. | |
TN2015000095A1 (en) | Macrolide derivatives, preparation thereof and therapeutic use thereof | |
EA033160B1 (en) | Compounds for the treatment of ischemia-reperfusion- related diseases | |
PH12015502703A1 (en) | Pharmaceutical compositions | |
PH12015500262A1 (en) | Novel pyridine derivatives | |
IN2013MU01219A (en) | ||
IN2013DE03665A (en) | ||
MD4291B1 (en) | Medicinal preparation for the treatment of otitis | |
MX2015009377A (en) | Radiolabeled compounds. | |
IN2013CH04330A (en) | ||
MX2015016320A (en) | Oxazolidinone-quinolone hybrid antibacterials for the parenteral treatment or prophylaxis of bacterial diseases. | |
UA87254U (en) | Compound 1,1-diethylcarboxy-2-methoxy-2-trifluoromethylethylene with potential physiological properties |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG4A | Patent for invention issued | ||
KA4A | Patent for invention lapsed due to non-payment of fees (with right of restoration) | ||
MM4A | Patent for invention definitely lapsed due to non-payment of fees |